News

News

July 2009

Sentinel Oncology, the Cambridge based cancer company focused on the discovery… read more

May 2009

Sentinel Oncology will be attending BIO Atlanta (18th-21st May 2009) and available for partnering discussions. Contact us… read more

February 2009

Sentinel Oncology, the Cambridge based cancer company focused on the discovery of novel treatments for… read more

January 2009

Sentinel Oncology is pleased to announce the appointment of Dr. John Dixon to the board of Directors.… read more

December 2008

“Sentinel Oncology is delighted to be recognised by ERBI in receipt of this award for innovation in drug discovery“said… read more

October 2008

Sentinel Oncology will be attending Biopartnering Europe at the QEII conference centre in London on 13-14th October. Why… read more

January 2008

Sentinel Oncology announce that their Checkpoint kinase 1 programme is available for pre-clinical partnering. To arrange… read more

October 2007

Sentinel Oncology Ltd secures £1.3M investment from Wellcome Trust to develop innovative cancer drugs. Funds will… read more

October 2007

Sentinel Oncology will be attending Biopartnering Europe at the QEII conference centre in London on 9-10th October. Why not… read more

July 2007

Sentinel appear as a case study for the East of England Development Agency (EEDA) grant for research and development. Gr… read more

Events

18th-22nd April 2009
AACR 100th Annual Meeting
Denver, CO, USA

18th-21st May 2009
BIO International Convention
Atlanta, GA, USA

25th June 2009
European Partnering and Investment Conference
London, UK